Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

EuroIntervention 2018;14:764-771 published online July 2018. DOI: 10.4244/EIJ-D-18-00396

Lars Kjoller-Hansen
Lars Kjøller-Hansen1*, MD, DMSc; Niels Bligaard2, MD; Henning Kelbæk1, MD, DMSc; Evald H. Christiansen3, MD, DMSc; Leif Thuesen4, MD, DMSc; Peter R. Hansen5, MD, PhD, DMSc; Thomas Engstrøm6, MD, PhD, DMSc; Anders Junker7, MD, PhD; Ulrik Abildgaard5, MD, DMSc; Jens F. Lassen6, MD, PhD; Jan S. Jensen5, MD, PhD, DMSc; Jørgen L. Jeppesen8, MD, DMSc; Anders M. Galløe1, MD, PhD; for the SORT OUT II investigators
1. Department of Cardiology, Zealand University Hospital, Roskilde, Denmark; 2. Department of Cardiology, Copenhagen University Hospital, Bispebjerg, Denmark; 3. Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark; 4. Department o

Aims: The aim of the study was to determine whether patients treated with drug-eluting stents in the proximal left anterior descending artery (LAD) carried a different long-term prognosis

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

clinical trialsclinical researchstent thrombosis
Coronary interventionsSTEMINSTEMIStable CADStents and scaffolds
Read next article
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study

Latest news